Booster Dose of sIPV Co-administered With MMR and HepA-I.

NCT06442449 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

889

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: sIPV
BIOLOGICAL: MMR
BIOLOGICAL: HepA-I

Sponsor

Sinovac Biotech Co., Ltd